Enliven Therapeutics, Inc 10-Q for FY2023 Q1
Enliven Therapeutics, Inc. (ELVN)
10-Q
2023-05-11
For: 2023-03-31
View Original
Added on
April 07, 2026
About this 10-Q
Enliven Therapeutics, Inc filed this 10-Q on May 11, 2023, covering the quarter ended March 31, 2023 (FY2023 Q1).
Headline figures
Quarter ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $14.72M
- compared with a net loss of $8.67M a year earlier
- Diluted EPS
- -$0.80
- compared with -$3.01 a year earlier